Enovix Corporation
NASDAQ:ENVX
10.08 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.768 | 5.272 | 7.381 | 0.2 | 0.042 | 0.021 | 1.093 | 0.008 | 5.101 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 4.423 | 7.072 | 19.769 | 16.809 | 14.235 | 12.248 | 10.356 | 6.629 | 5.739 | 0.515 | 0.12 | 0.104 | 0.112 | 1.631 | 0.993 | 1.153 | 0.858 | 0.371 |
| Gross Profit
| -0.655 | -1.8 | -12.388 | -16.609 | -14.193 | -12.227 | -9.263 | -6.621 | -0.638 | -0.515 | -0.12 | -0.104 | -0.112 | -1.631 | -0.993 | -1.153 | -0.858 | -0.371 |
| Gross Profit Ratio
| -0.174 | -0.341 | -1.678 | -83.045 | -337.929 | -582.238 | -8.475 | -827.625 | -0.125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 29.065 | 48.788 | 34.582 | 13.508 | 16.553 | 23.749 | 15.545 | 13.948 | 15.827 | 12.731 | 12.437 | 10.301 | 9.523 | 5.589 | 5 | 3.807 | 3.23 | 2.405 |
| General & Administrative Expenses
| 0 | 6.206 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.661 | 0 | 0.661 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 13.342 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.887 | 0 | 3.887 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 20.884 | 19.548 | 17.807 | 17.245 | 16.688 | 27.274 | 15.425 | 13.11 | 11.566 | 11.869 | 12.205 | 8.791 | 4.548 | 4.161 | 1.947 | 1.486 | 1.28 | 1 |
| Other Expenses
| 0.242 | 0.466 | -0.433 | 0 | -0.001 | 0.021 | 0.001 | 1.826 | 0.496 | 0.022 | 0.014 | -0.05 | 0.015 | -0.003 | 0.003 | 0.001 | 0 | 0 |
| Operating Expenses
| 49.949 | 68.336 | 52.389 | 30.753 | 33.241 | 51.023 | 30.97 | 27.058 | 27.393 | 24.6 | 24.642 | 19.092 | 14.071 | 9.75 | 6.947 | 5.293 | 4.292 | 7.204 |
| Operating Income
| -88.75 | -70.136 | -64.777 | -50.383 | -51.845 | -63.25 | -45.154 | -33.679 | -28.031 | -25.115 | -24.762 | -19.196 | -14.183 | -11.381 | -7.94 | -6.446 | -5.368 | -3.776 |
| Operating Income Ratio
| -23.554 | -13.303 | -8.776 | -251.915 | -1,234.405 | -3,011.905 | -41.312 | -4,209.875 | -5.495 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -71.564 | 21.586 | 1.607 | 34.198 | -18.752 | -10.353 | 33.973 | -48.334 | 26.896 | 67.822 | -59.806 | 8.41 | 0.015 | -4.784 | -5.402 | -7.03 | 0.218 | -3.906 |
| Income Before Tax
| -120.533 | -46.649 | -60.671 | -16.185 | -64.306 | -73.603 | -11.181 | -82.013 | -1.135 | 42.707 | -84.568 | -10.838 | -14.303 | -16.165 | -13.342 | -13.476 | -5.15 | -7.682 |
| Income Before Tax Ratio
| -31.989 | -8.848 | -8.22 | -80.925 | -1,531.095 | -3,504.905 | -10.23 | -10,251.625 | -0.223 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -4.586 | -0.152 | 0.633 | 0 | 1.269 | 23.193 | -58.103 | 50.16 | -26.4 | -135.622 | 59.82 | -8.46 | -0.015 | 9.565 | 5.405 | 7.03 | 0 | 0 |
| Net Income
| -115.872 | -46.368 | -59.977 | -16.185 | -64.306 | -96.796 | 46.922 | -132.173 | 25.265 | 178.329 | -84.568 | -10.838 | -14.303 | -16.165 | -13.342 | -13.476 | -5.15 | -7.682 |
| Net Income Ratio
| -30.752 | -8.795 | -8.126 | -80.925 | -1,531.095 | -4,609.333 | 42.93 | -16,521.625 | 4.953 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.67 | -0.28 | -0.36 | -0.1 | -0.41 | -0.62 | 0.3 | -0.86 | 0.17 | 1.18 | -0.6 | -0.081 | -0.099 | -0.11 | -0.092 | -0.093 | -0.085 | -0.13 |
| EPS Diluted
| -0.67 | -0.28 | -0.36 | -0.1 | -0.41 | -0.62 | 0.3 | -0.86 | 0.17 | 1.16 | -0.6 | -0.081 | -0.099 | -0.11 | -0.092 | -0.093 | -0.085 | -0.13 |
| EBITDA
| -41.093 | -41.136 | -38.075 | -50.383 | -40.616 | -46.812 | -63.275 | -28.858 | -26.183 | -92.467 | -24.295 | -18.559 | -14.168 | -6.459 | -7.794 | -6.445 | -5.223 | -3.632 |
| EBITDA Ratio
| -10.906 | -7.803 | -5.159 | -251.915 | -967.048 | -2,229.143 | -57.891 | -3,607.25 | -5.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |